Second-hand smoke falls to MR

Article

The 30-year search for direct quantitative evidence linking second-hand smoke and lung disease ended at the 2007 RSNA meeting with a study that made the connection.

The 30-year search for direct quantitative evidence linking second-hand smoke and lung disease ended at the 2007 RSNA meeting with a study that made the connection. Collaborators at University of Virginia School of Medicine in Charlottesville and Children's Hospital of Philadelphia used inhaled hyperpolarized helium-3 and diffusion MRI to break through long-standing technical barriers. MR physicist Dr. Chengbo Wang, Ph.D., explained that high fMRI apparent diffusion coefficient values correlated with enlarged lung aveoli and damaged lungs, while low ADC values related to small aveoli and normal pulmonary function. Elevated ADC was found in 4% of subjects with infrequent exposure to second-hand smoke (A), 27% with high exposure (B), and 67% of current and former smokers. The findings could help build support for legislation that would tighten restrictions against public exposure to second-hand smoke, Wang said. (image provided by C. Wang).

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.